On Jan. 15, the House Energy and Commerce Subcommittee on Health held a hearing on discrepancies between state and federal medical cannabis policy and federal roadblocks to clinical research. Many felt the conversation was long overdue.
“I honestly never dreamed I would see, in my lifetime, such progress and discussion on the need for more research on cannabis and CBD at the federal level,” says Ellen Lenox Smith, Co-Director of Medical Cannabis Advocacy for U.S. Pain Foundation. “But to my excitement, it happened, and it was a thorough discussion, lasting three and a half hours.”
By Jahan Marcu, Ph.D., Chief Science Officer for Americans for Safe Access
With over 100,000 active members in all 50 states, Americans for Safe Access (ASA) is the largest national member-based organization of patients, medical professionals, scientists, and concerned citizens promoting safe and legal access to cannabis for therapeutic use and research.
ASA works to overcome political and legal barriers by creating policies that improve access to medical cannabis. One method is to share the facts when it comes to research.